Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;5(2):7.
doi: 10.7603/s40681-015-0007-8. Epub 2015 Jun 1.

Impact of Cholesterol on Disease Progression

Affiliations
Free PMC article

Impact of Cholesterol on Disease Progression

Chun-Jung Lin et al. Biomedicine (Taipei). .
Free PMC article

Abstract

Cholesterol-rich microdomains (also called lipid rafts), where platforms for signaling are provided and thought to be associated with microbe-induced pathogenesis and lead to cancer progression. After treatment of cells with cholesterol disrupting or usurping agents, raft-associated proteins and lipids can be dissociated, and this renders the cell structure nonfunctional and therefore mitigates disease severity. This review focuses on the role of cholesterol in disease progression including cancer development and infectious diseases. Understanding the molecular mechanisms of cholesterol in these diseases may provide insight into the development of novel strategies for controlling these diseases in clinical scenarios.

Similar articles

See all similar articles

Cited by 13 articles

See all "Cited by" articles

References

    1. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry. 1992;31:4737–49. - PubMed
    1. Lewis GF. Determinants of plasma HDL concentrations and reverse cholesterol transport. Curr Opin Cardiol. 2006;21:345–52. - PubMed
    1. Hampton R, Dimster-Denk D, Rine J. The biology of HMG-CoA reductase: the pros of contra-regulation. Trends Biochem Sci. 1996;21:140–5. - PubMed
    1. Barrios-Gonzalez J, Miranda RU. Biotechnological production and applications of statins. Appl Microbiol Biotechnol. 2010;85:869–83. - PubMed
    1. Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res. 2011;52:6–34. - PMC - PubMed

LinkOut - more resources

Feedback